Revolutionizing Lung Cancer Screening: Oatmeal Health & Coreline Soft Partner to Bridge the Equity Gap
Lung cancer remains the deadliest cancer globally, claiming more lives annually than colon, breast, and prostate cancers combined. Yet, despite the availability of effective screening methods, a staggering 94.2% of eligible individuals remain unscreened. This disparity is particularly acute within underserved communities, highlighting a critical gap in healthcare access. Now, a groundbreaking partnership between Oatmeal Health and Coreline Soft aims to change that, leveraging the power of Artificial Intelligence (AI) to democratize lung cancer screening and save lives.
A Strategic Alliance for Early Detection
Oatmeal Health, a leader in AI-driven healthcare solutions for Federally Qualified Health Centers (FQHCs), has joined forces with Coreline Soft, a publicly traded innovator in AI imaging based in South Korea and the U.S. This collaboration will co-develop and distribute advanced AI-powered lung cancer screening solutions across the United States, with a focused commitment to equitable access.
The core mission? To proactively identify and screen high-risk patients who are currently falling through the cracks – individuals who would likely never receive potentially life-saving early detection. This isn’t just about technology; it’s about fundamentally changing the landscape of lung cancer care.
The Challenge: Why Aren’t More People Screened?
customary lung cancer screening faces important hurdles.Cost,geographic limitations,and a lack of awareness all contribute to low participation rates. For underserved populations, these barriers are amplified. FQHCs, which serve as vital healthcare hubs for these communities, are often under-resourced and lack the infrastructure for widespread screening programs.
Oatmeal Health directly addresses these challenges with a unique, zero-cost solution tailored for FQHCs and cancer centers. They are already actively deploying their platform in California, Arizona, Oklahoma, and Massachusetts, successfully identifying and screening thousands of at-risk patients.
How Oatmeal Health’s AI Platform Works: A Seamless Workflow
The Oatmeal Health platform isn’t just about identifying risk; it’s about streamlining the entire screening process for both patients and providers. Here’s a breakdown of the key components:
AI-Powered Patient Identification: The platform intelligently scans Electronic Health Records (EHRs) to pinpoint high-risk individuals who meet screening criteria. This proactive approach ensures no eligible patient is overlooked.
Virtual Consultations & Shared Decision-Making: A Nurse Practitioner (NP) conducts convenient virtual visits, providing patients with complete data and facilitating informed decisions about screening.
Reimbursement & Financial Viability: The platform leverages new AI CPT codes (0721T),currently reimbursed at approximately $650 per scan,enabling FQHCs and imaging providers to recoup costs.
Risk-Based Revenue Sharing: Oatmeal Health offers a zero-cost, zero-hassle model for providers, coupled with a performance-based revenue sharing agreement, incentivizing widespread adoption.
Coreline Soft: Enhancing imaging with AI Expertise
Coreline Soft brings a wealth of experience in AI imaging to the partnership. Their platform is already integrated into numerous U.S. health systems, processing a significant volume of low-dose CT scans annually. This existing infrastructure, combined with the guidance of leading lung cancer advocate Jim Baranski (Executive Director of the Lung Cancer Foundation of America), will ensure the scalable and effective implementation of the combined solution.
The Economic Impact: Saving Lives and Reducing Costs
The potential impact of this collaboration extends beyond improved patient outcomes. early detection of lung cancer is projected to save an estimated $300,000 to $500,000 per patient. By identifying cancer at earlier, more treatable stages, the partnership aims to substantially reduce healthcare costs while, most importantly, saving lives.
Looking Ahead: FDA Submission and National Expansion
Oatmeal Health is currently focused on securing capital to fuel national distribution, expand its FQHC network, and finalize its FDA Computer-Aided Detection and Diagnosis (CADx) submission, anticipated in the first quarter of 2026. This submission will further validate the platform’s accuracy and efficacy, paving the way for broader adoption and ultimately, a future where early lung cancer detection is accessible to all.
Frequently Asked Questions About AI Lung Cancer Screening
Q: What is AI-powered lung cancer screening, and how does it differ from traditional methods? A: AI lung cancer screening utilizes artificial intelligence algorithms to analyze medical images (like
